Matters of legal in nature including licensing, intellectual property, and lawsuits.
CHELMSFORD, Mass., Sept. 6, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that Dusty Tenney, President Sample Management, will be leaving Brooks effective September 6, 2019. “We are deeply appreciative of the contributions Dusty has made to the Sample Management business since joining Brooks in 2014,” said Steve Schwartz, President and CEO. “Dusty has... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Sep. 6, 2019– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its President and CEO Patrick Decker and Senior Director of Investor Relations Matt Latino will participate in investor meetings and present at 9:55 a.m. Pacific Standard Time... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Sep. 4, 2019– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its President and CEO Patrick Decker and Senior Director of Investor Relations Matt Latino will participate in investor meetings and present at 1:30 p.m. Pacific Standard Time... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Sep. 4, 2019– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Chief Financial Officer Mark Rajkowski and Senior Director of Investor Relations Matt Latino will participate in investor meetings at the Stifel Baltusrol Executive Summit, at the... Read more
BREA, Calif., Sept. 4, 2019 /PRNewswire/ — Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced it has launched a roadshow for the initial public offering (IPO) of its common stock. Envista is offering 26,768,000 shares of its common stock in the IPO. The underwriters will also have a 30-day option to purchase... Read more
Basel, 29 August 2019 Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq This launch represents an important step in Roche’s personalised healthcare strategy to fit treatments to patients who can benefit most from a specific medicine Each year 300,000... Read more
Basel, 29 August 2019 European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer The Tecentriq combination marks the first cancer immunotherapy regimen to be available in Europe for triple-negative breast cancer – an aggressive and difficult-to-treat disease Approval based on the Phase III IMpassion130 study, which showed... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Aug. 27, 2019– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Senior Director of Investor Relations, Matt Latino, will participate in investor meetings at the Seaport Global 2019 Energy and Industrials Conference at the JW Marriott Hotel... Read more
CONTACT: Joe Heinzelmann, Neogen Corporation, 517/372-9200 LANSING, Mich., Aug. 21, 2019 — Neogen Corporation (Nasdaq: NEOG) announced AOAC has validated NeoSeek™ for STEC, a proprietary testing platform that determines the genetic composition of bacteria in a food sample. The newly validated test detects and identifies seven Shiga toxin-producing strains of E. coli (STEC) known to cause severe human... Read more
CE-Marked Solution Gives Pregnant Women Widespread Access to Non-Invasive Prenatal Testing WALTHAM, Mass. – August 21, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its Vanadis® fully automated non-invasive prenatal testing (NIPT) system has been validated in an external clinical study, titled “Clinical Validation of a... Read more